Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology

Journal of Urology

Volumn 169, Issue 5, 2003, Pages 1858-1864

  Jan Schrader, Andres ^a   Lauber, Joerg ^a   Lechner, Oskar ^a   Heidenreich, Axel ^a   Hofmann, Rainer ^a   Buer, Jan ^a  

^a NONE

Author keywords

Gene expression profiling; Reverse transcriptase polymerase chain reaction; RNA; Urologic neoplasms

Indexed keywords

CYTOCHROME P450 ISOENZYME; CYTOKERATIN 20; DOUBLE STRANDED DNA; ETHIDIUM BROMIDE; FLUORESCENT DYE; PROSTATE SPECIFIC ANTIGEN;

AMPLICON; ANALYTIC METHOD; BLADDER CANCER; CANCER GRADING; CANCER STAGING; COST; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; FLUORESCENCE; GENE EXPRESSION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CANCER; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; PROCESSING; PROSTATE CANCER; PUBLICATION; QUANTITATIVE ANALYSIS; REAL TIME REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; TECHNIQUE; TREATMENT INDICATION;

EID: 0037405510     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000047363.03411.6b     Document Type: Review

References (30)

1. Solinas, A., Brown, L. J., McKeen, C., Mellor, J. M., Nicol, J., Thelwell, N. et al: Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res, 29: E96, 2001
2. Bustin, S. A.: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol, 25: 169, 2000
3. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R. and Mathieu, C.: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods, 25: 386, 2001
4. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. et al: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res, 52: 6110, 1992
5. Polascik, T. J., Oesterling, J. E. and Partin, A. W.: Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol, 162: 293, 1999
6. Henke, W., Jung, M., Jung, K., Lein, M., Schlechte, H., Berndt, C. et al: Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer, 70: 52, 1997
7. Verhaegen, M., Ioannou, P. C. and Christopoulos, T. K.: Quantification of prostate-specific antigen mRNA by coamplification with a recombinant RNA internal standard and microtiter well-based hybridization. Clin Chem, 44: 1170, 1998
8. Ylikoski, A., Sjoroos, M., Lundwall, A., Karp, M., Lovgren, T., Lilja, H. et al: Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA. Clin Chem, 45: 1397, 1999
9. Galvan, B. and Christopoulos, T. K.: Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA. Clin Biochem, 30: 391, 1997
10. Gelmini, S., Tricarico, C., Vona, G., Livi, L., Melina, A. D., Serni, S. et al: Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. Clin Chem Lab Med, 39: 385, 2001
11. Straub, B., Muller, M., Krause, H., Schrader, M., Goessl, C., Heicappel, R. et al: Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction. Urology, 58: 815, 2001
12. Linja, M. J., Savinainen, K. J., Saramaki, O. R., Tammela, T. L., Vessela, R. L. and Visakorpi, T.: Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res, 61: 3550, 2001
13. Helenius, M. A., Saramaki, O. R., Linja, M. J., Tammela, T. L. and Visakorpi, T.: Amplification of urokinase gene in prostate cancer. Cancer Res, 61: 5340, 2001
14. Inoue, T., Nakanishi, H., Inada, K.-I., Hioki, T., Tatematsu, M. and Sugimura, Y.: Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells. J Urol, 166: 2134, 2001
15. Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T. et al: CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem Biophys Res Commun, 277: 776, 2000
16. De Kok, J. B., Schalken, J. A., Aalders, T. W., Ruers, T. J., Willems, H. L. and Swinkels, D. W.: Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer, 87: 217, 2000
17. Paradis, V., Bieche, I., Dargere, D., Bonvoust, F., Ferlicot, S., Olivi, M. et al: hTERT expression in sporadic renal cell carcinomas. J Pathol, 195: 209, 2001
18. Chuanzhong, Y., Ming, G., Fanglin, Z., Haijiao, C., Zhen, L., Shiping, C. et al: Real-time quantitative reverse transcription-PCR assay for renal cell carcinoma-associated antigen G250. Clin Chim Acta, 318: 33, 2002
19. Tricarico, C., Salvadori, B., Villari, D., Nicita, G., Della Melina, A., Pinzani, P. et al: Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. Int J Biol Markers, 14: 247, 1999
20. Efferth, T., Bode, M. E., Schulten, H. G., Thelen, P., Granzen, B., Beniers, A. J. et al: Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas. Int J Oncol, 19: 163, 2001
21. Efferth, T., Thelen, P., Schulten, H. G., Bode, M. E., Granzen, B., Beniers, A. J. et al: Differential expression of the multidrug resistance-related protein MRP1 in the histological compartments of nephroblastomas. Int J Oncol, 19: 367, 2001
22. Span, P. N., Thomas, C. M., Heuvel, J. J., Bosch, R. R., Schalken, J. A., vd Locht, L. et al: Analysis of expression of chorionic gonadotrophin transcripts in prostate cancer by quantitative Taqman and a modified molecular beacon RT-PCR. J Endocrinol, 172: 489, 2002
23. Peirce, S. K., Chen, W. Y. and Chen, W. Y.: Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol, 171: R1, 2001
24. Calvo, A., Xiao, N., Kang, J., Best, C. J., Leiva, I., Emmert-Buck, M. R. et al: Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res, 62: 5325, 2002
25. de Kok, J. B., Verhaegh, G. W., Roelofs, R. W., Hessels, D., Kiemeney, L. A., Aalders, T. W. et al: DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res, 62: 2695, 2002
26. Savinainen, K. J., Saramaki, O. R., Linja, M. J., Bratt, O., Tammela, T. L., Isola, J. J. et al: Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. Am J Pathol, 160: 339, 2002
27. Burger, M. J., Tebay, M. A., Keith, P. A., Samaratunga, H. M., Clements, J., Lavin, M. F. et al: Expression analysis of deltacatenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int J Cancer, 100: 228, 2002
28. Bieche, I., Latil, A., Parfait, B., Vidaud, D., Laurendeau, I., Lidereau, R. et al: CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors. Eur Urol, 41: 335, 2002
29. Schrader, A. J., Lechner, O., Templin, M., Dittmar, K. E., Machtens, S., Mengel, M. et al: CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer, 86: 1250, 2002
30. Klade, C. S., Dohnal, A., Furst, W., Sommergruber, W., Heider, K. H., Gharwan, H. et al: Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma. Int J Cancer, 97: 217, 2002